ArticleDiabetes/metabolism research and reviews2025
Neck Circumference and the Heart: Unveiling a New Anthropometric Marker for LVH Risk in Type 2 Diabetes-The TESEO Study.
Article in Diabetes/metabolism research and reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neck Circumference and the Heart: Unveiling a New Anthropometric Marker for LVH Risk in Type 2 Diabetes-The TESEO Study.Diabetes/metabolism research and reviews · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
aimLeft ventricular hypertrophy (LVH) is highly prevalent among individuals with type 2 diabetes (T2DM) and is a predictor of adverse cardiovascular outcomes. Visceral and ectopic fat accumulation contributes to cardiometabolic risk. Neck circumference (NC) and the neck circumference-to-height index (NCI) have emerged as potential markers of ectopic adiposity, yet their association with LVH remains unexplored. The aim of this study was to evaluate the relationship between NC and NCI with the presence of LVH in a contemporary cohort of T2DM patients. MATERIALS AND
methodsT2DM patients were consecutively enroled in the TESEO study. Participants underwent comprehensive clinical, biochemical, bioimpedance and echocardiographic evaluations. Multivariable logistic regression models were used to examine the independent associations between NC/NCI and LVH, adjusting for age, sex, mean arterial blood pressure, HbA1c, triglycerides, estimated glomerular filtration rate, urinary albumin-to-creatinine ratio and treatments.
results29% of participants had LVH. NC and NCI were higher among individuals with LVH. After full adjustment, NC and NCI were independently associated with 26% and 57% higher odds of LVH, respectively. Stratified analyses revealed a stronger association in men (OR 1.65, 95% CI: 1.25-2.18) than in women (OR 1.49, 95% CI: 1.19-1.87). NC and NCI outperformed BMI and waist circumference in their association with LVH. ROC curve analyses confirmed that NCI has good discriminatory power for identifying individuals with and without LVH.
conclusionsNC and NCI are independently associated with LVH in T2DM patients and they may represent practical, non-invasive markers to enhance cardiovascular risk stratification in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.